The evolving landscape for compounded GLP-1 drugs

Dec 24, 2024

1 min read

Updated: Mar 2, 2025

A lawsuit from a compounding trade group in October claimed tirzepatide was still in shortage, forcing the FDA to reassess.

FDA says tirzepatide shortage is over after taking a second look

https://search.app/fZUzQGsJKYDmf1dT8

Recent Posts

See All

Early TAVR for asymptomatic aortic stenosis

There have been many ongoing trials on this topic and they are finally starting to conclude that intervening early, even when the patient is asymptomatic, is beneficial once echocardiogram shows the p

Vaginal Estrogen and Stroke Risk

We get a lot of questions from women who would benefit from vaginal/topical estrogen but are appropriately concerned about increased risk for heart attack and stroke with estrogen supplementation. A n

Insomnia in Primary Care

Comments